Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...

Our Phase 1/2a clinical trial has demonstrated that the use of this stem cell population in humans is safe and effective in treating hard to heal diabetic foot ulcers." "We are extremely pleased ...

Diabetic foot screening intervals could be extended beyond 1 year for patients at very low risk for diabetic foot complications.

The global wound evacuators market is on a steady growth trajectory, with its size estimated at USD 383.3 million in 2022, and projected to reach USD 593.6 million by 2032, expanding at a CAGR of 4.1% ...

foot ulcers and infection may be the presenting sign of diabetes. 1. The ability to performhemodynamic and anatomic vascular assessment with revascularization, as necessary using both physical ...

Non-Ribosomal Peptide Antibiotics Dominated the Market with USD 1.4 Billion Valuation in 2024 Due to Enhanced EfficacyDublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Antibiotics Market ...

Venous hypertension affects veins in the legs and the way blood circulates to the heart. Learn about symptoms of venous ...

HC Wainwright lifted their Q1 2025 EPS estimates for Spectral AI in a note issued to investors on Wednesday, April 2nd. HC ...

The Community Health Worker Institute (CHWI) at Montefiore, a novel program that improves the wellbeing of local residents ...

Meet the changemakers redefining healthcare in India through innovation, compassion, and purpose-driven leadership. From ...

Post Liberation Day, life science companies are clarifying the likely impact of Trump's tariffs – and the news is largely positive.